Peter the Bridge, Saint Petersburg, Russia

The NEOMED Institute is participating at the 2nd Annual 2018 Franco-Quebecois Forum – Innovation in health (FFQIS) in Paris

April 25th, 2018 | No Comments

Montreal, Quebec, Canada April 25th, 2018 – The NEOMED Institute today announced the participation of Donald Olds, its President & CEO, in the 2018 Franco-Québécois Forum for Health Innovation (FFQIS) in Paris, that will be held on May 15thand 16th, and where he will be a panelist on a round table discussion entitled: “Quebec : a unique innovative healthcare ecosystem”. This 2ndannual FFQIS conference is focused on innovation ecosystems, medical imaging, biomaterials, biomechanics and e-health and seeks to bring together industry experts and thought leaders from France and Quebec.

This Forum is open to academic, hospital and industrial researchers engaged in the field of medical technologies. The event includes scientific presentations, meetings and round table discussions intended to promote collaboration between French and Quebec participants through exchanges between scientists and industrialists to promote collaborative projects and technological innovation in health.

“It’s a great opportunity to continue to build on our strategic relationship with Génopôle D’Evry and to strengthen our interactions with French academic, industrial researchers and biotechnology companies as well as explore potential future collaborations. I am very excited to participate in the round table discussion on May the 16th, during which I will have the opportunity to describe the unique and innovative healthcare ecosystem that is now the NEOMED Institute in Quebec” says Donald Olds, President & CEO of the NEOMED Institute. “I encourage all of our network companies and scientists to review the FFQIS program and consider whether their attendance at this conference could be of interest to develop long-lasting scientific and business relationships with a very dynamic French life sciences sector.”   


About FFQIS :

Date: May 15th & 16th, 2018

Place: ICM – Institut du Cerveau et de la Moelle Epinière

Hôpital Pitié Salpêtrière – 47 Boulevard Hôpital, 75013 Paris


Registration Cost – Free

B2B Partnering Available – Yes


About the NEOMED Institute

The NEOMED Institute is a successful and innovative Canadian not-for-profit R&D organization whose mission is to enable and accelerate the commercialization of life science discoveries. To accomplish this mission, NEOMED Institute operates two complementary and integrated divisions:

  • NEOMED Therapeutics in-licenses promising scientific discoveries from Canadian and other academic centers and research institutes and then funds and develops these programs to stages that are attractive for partnering or stand-alone financing. All proceeds from successful out-licensing and exits are re-invested in new pipeline projects.
  • NEOMED Innovation Center operates a world-class life sciences ecosystem in Montreal, Quebec, that was created as an enabling environment for biotechnology and contract research organizations to establish, grow and prosper. Today the NEOMED Innovation Centre hosts 30 life sciences companies employing over 350 people who operate in our two state-of-the-art R&D centres comprising over 200,000 sq. ft. of fully equipped laboratories and benefit from NEOMED’s shared services model (analytical/in vivo pharmacology, etc.) that enables a culture of collaboration and scientific innovation.

The NEOMED Institute is funded by our pharmaceutical partners, the Ministère de l’Économie de la Science et de l’Innovation du Québec, and the Networks of Centres of Excellence (NCE) of Canada as well as from revenue generated from the out-licensing/sale of our research pipeline projects and the operation of our facilities.


For more information, please contact :

Donald Olds

President & CEO, NEOMED Institute


Share this

Similar News

image articles
30 May 2019

CDRD and NEOMED Institute Join Forces to Create a New Pan-Canadian Enterprise adMare BioInnovations

Read complete news
image articles
14 May 2019

Hope on the horizon for hard-to-treat breast cancers

Read complete news
© 2019 NEOMED Institute. All Rights Reserved. // Solutions Web Globalia